Pure Global AI
NCT06397339Recruiting

Indian Transforming Alzheimer's Care Training (INTACT)

Washington State UniversityClinicalTrials.govother
Verified
Study focus
Disease/Condition
Alzheimer Disease
Drug/Device/Intervention
INTACT Program
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Washington State University
Location
Seattle, United States of America
Timeline & enrollment
Phase
N/A
Start date
Oct 05, 2022
End date
Apr 30, 2026
Enrollment
28 participants
Primary outcome

Clinic Level - new diagnoses of ADRD and MCI (Aim 2),PCP level - care confidence (Aim 1),Patient level - quality of care 1 (Aim 3),Patient level - quality of care 2 (Aim 3),Patient level - quality of care 3 (Aim 3),Patient level - quality of care 4 (Aim 3),Patient level - quality of care 5 (Aim 3),Patient level - quality of care 5 (Aim 3)

Summary

INTACT will utilize a group-randomized trial, to test the effectiveness of a culturally
 informed provider training and dementia friendly clinic intervention for detection and
 appropriate management of AI/AN patients with ADRD and MCI in 28 urban and rural clinics
 serving AI/ANs.

ICD-10 classifications
Alzheimer diseaseAlzheimer disease, unspecifiedOther Alzheimer diseaseDementia in Alzheimer diseaseDementia in Alzheimer disease, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06397339
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06397339 through Pure Global AI's free database. This phase not specified trial is sponsored by Washington State University and is currently Recruiting. The study focuses on Alzheimer Disease. Target enrollment is 28 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.